Carregant...
Use of early chemotherapy for hormone-sensitive prostate cancer: time for CHAARTED
CHAARTED was an ECOG-led phase III trial looking at early chemotherapy with the use of docetaxel in addition to androgen deprivation therapy (ADT) versus ADT alone in hormone-sensitive prostate cancer. The positive results of the trial showing marked improvement in overall survival in those who rece...
Guardat en:
| Publicat a: | Asian J Androl |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854101/ https://ncbi.nlm.nih.gov/pubmed/26510505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.164920 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|